Factors that Influence Growth Rates of Abdominal Aortic Aneurysms. Analysis of a Mexican Cohort.

Vascular and endovascular surgery Pub Date : 2024-11-01 Epub Date: 2024-07-21 DOI:10.1177/15385744241265758
Luis O Bobadilla-Rosado, Javier E Anaya-Ayala, Eros Santos-Chavez, Julio Navarro, Ignacio Martinez-Quesada, Hugo Laparra-Escareno, Nina Mendez-Dominguez, Carlos A Hinojosa
{"title":"Factors that Influence Growth Rates of Abdominal Aortic Aneurysms. Analysis of a Mexican Cohort.","authors":"Luis O Bobadilla-Rosado, Javier E Anaya-Ayala, Eros Santos-Chavez, Julio Navarro, Ignacio Martinez-Quesada, Hugo Laparra-Escareno, Nina Mendez-Dominguez, Carlos A Hinojosa","doi":"10.1177/15385744241265758","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Abdominal Aortic Aneurysms (AAA) growth remains a process not fully understood. The objective of this study was to analyze risk factors associated with changes in AAA diameter in a Mexican cohort.</p><p><strong>Methods: </strong>An observational study in which we analyzed the entirely of patients in which an AAA was reported in a Computed Tomography (CT) study from 2014 to 2021 who had a follow-up CT. We divided them by groups depending on the diagnosis of type 2 diabetic mellitus and pharmacological history (diabetic vs non-diabetic, metformin vs non-metformin intake and statin vs non-statin intake). We compared pre and post follow-up AAA diameters using paired t-tests. A multivariate analysis was performed in order to identify independent variables associated with an increased growth rate. Statistical analysis was performed on Stata 17.</p><p><strong>Results: </strong>During the studied period 72 (39.77%) patients had a follow-up CT. Mean age was 75 years (±9.05) and 52 (72.22%) were men. When comparing infra-renal largest diameter through time based on metformin intake, a significant difference was found only in the metformin non-intake group (42.05 ± 12.54 vs45.34 ± 12.06 [<i>P</i> = 0.02]), in contrast the metformin intake group measures were non-significantly different (36.13 ± 7.04 vs 37.00 ± 4.51; <i>P</i> = 0.57) through follow-up. In the multivariate analysis AAA largest diameter at diagnosis correlated with significantly increased growth rate (coeff = 0.06, <i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>AAA diameters appear to change through time in a non-linear pattern influenced by different epidemiological and clinical factors. Metformin intake appears to promote a stability in AAA diameter growth in our studied population.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular and endovascular surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15385744241265758","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/21 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Abdominal Aortic Aneurysms (AAA) growth remains a process not fully understood. The objective of this study was to analyze risk factors associated with changes in AAA diameter in a Mexican cohort.

Methods: An observational study in which we analyzed the entirely of patients in which an AAA was reported in a Computed Tomography (CT) study from 2014 to 2021 who had a follow-up CT. We divided them by groups depending on the diagnosis of type 2 diabetic mellitus and pharmacological history (diabetic vs non-diabetic, metformin vs non-metformin intake and statin vs non-statin intake). We compared pre and post follow-up AAA diameters using paired t-tests. A multivariate analysis was performed in order to identify independent variables associated with an increased growth rate. Statistical analysis was performed on Stata 17.

Results: During the studied period 72 (39.77%) patients had a follow-up CT. Mean age was 75 years (±9.05) and 52 (72.22%) were men. When comparing infra-renal largest diameter through time based on metformin intake, a significant difference was found only in the metformin non-intake group (42.05 ± 12.54 vs45.34 ± 12.06 [P = 0.02]), in contrast the metformin intake group measures were non-significantly different (36.13 ± 7.04 vs 37.00 ± 4.51; P = 0.57) through follow-up. In the multivariate analysis AAA largest diameter at diagnosis correlated with significantly increased growth rate (coeff = 0.06, P < 0.05).

Conclusions: AAA diameters appear to change through time in a non-linear pattern influenced by different epidemiological and clinical factors. Metformin intake appears to promote a stability in AAA diameter growth in our studied population.

影响腹主动脉瘤生长速度的因素。墨西哥队列分析
目的:腹主动脉瘤(AAA)的生长过程尚不完全清楚。本研究旨在分析墨西哥队列中与 AAA 直径变化相关的风险因素:在这项观察性研究中,我们分析了 2014 年至 2021 年期间在计算机断层扫描(CT)研究中报告有 AAA 并进行了后续 CT 检查的所有患者。我们根据 2 型糖尿病诊断和用药史(糖尿病与非糖尿病、二甲双胍摄入与非二甲双胍摄入、他汀与非他汀摄入)将其分组。我们使用配对 t 检验比较了随访前后 AAA 的直径。我们还进行了多变量分析,以确定与增长速度相关的独立变量。统计分析在 Stata 17 中进行:在研究期间,72 名(39.77%)患者进行了 CT 随访。平均年龄为 75 岁(±9.05),男性 52 人(72.22%)。根据二甲双胍摄入量比较不同时间段的肾下最大直径,发现只有未摄入二甲双胍组存在显著差异(42.05 ± 12.54 vs45.34 ± 12.06 [P = 0.02]),相反,摄入二甲双胍组的随访测量结果无显著差异(36.13 ± 7.04 vs 37.00 ± 4.51; P = 0.57)。在多变量分析中,诊断时的 AAA 最大直径与显著增长的增长率相关(系数 = 0.06,P < 0.05):结论:AAA直径似乎会随着时间的推移发生非线性变化,并受到不同流行病学和临床因素的影响。在我们研究的人群中,二甲双胍的摄入似乎促进了 AAA 直径增长的稳定性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信